Acadia Pharmaceuticals
develop neurological disorder therapies
- B2C
About Acadia Pharmaceuticals
Develop and commercialize FDA-approved treatments for neurological disorders, focusing on underserved diseases like Parkinson's psychosis and Rett syndrome.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
- Headquarters
- san diego, california, United States
- Founded
- 1993
- Revenue
- $1.1BFY2025, publicly reported
- Website
- acadia.com
Acadia Pharmaceuticals at a glance
Acadia Pharmaceuticals is a B2C company in the Pharmaceutical Manufacturing industry, headquartered in san diego, california, United States.
Acadia Pharmaceuticals was founded in 1993.
Acadia Pharmaceuticals has 1,001–5,000 employees.
Acadia Pharmaceuticals's revenue is $1.1B (FY2025, publicly reported).
Selling to companies like Acadia Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies